Login / Signup

HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment.

Emma S ScottRachel T McGrathAndrzej S JanuszewskiDaniel CalandroAnandwardhan A HardikarDavid Norman O'NealGregory FulcherAlicia J Jenkins
Published in: BMJ open (2019)
In clinical practice with T1DM adults relative to MDI, CSII therapy is associated with lower HbA1c GV.
Keyphrases
  • clinical practice
  • type diabetes
  • low dose
  • glycemic control
  • stem cells
  • mesenchymal stem cells
  • ultrasound guided
  • adipose tissue
  • skeletal muscle
  • insulin resistance